Abstract
The objective of this study was to assess the impact of Achillea ageratum L. (A. ageratum) essential oil (EO) administered at a dosage of 50 mg/kg on triton WR-1339-induced hyperlipidemia in Wistar rats. The phytochemical composition of the EO was analyzed using gas chromatography-mass spectrometry (GC-MS), revealing the prevalence of oxygen-containing monoterpenes, and oxygen-containing sesquiterpenes. Furthermore, the principal constituents of A. ageratum EO included artemisyl acetate (54.09%), α-santalol (14.99%), and yomogi alcohol (8.98 %). The in vivo toxicity of this EO was assessed using the acute toxic class (ATC) method, revealing no adverse effects or mortality. The estimated LD50 exceeded 2 g/kg. Triton WR-1339 administration resulted in significant increase in hyperlipidemia-associated parameters, including total cholesterol (TC), triglycerides (TGs), low-density lipoprotein cholesterol (LDL-c), very low-density lipoprotein cholesterol (VLDL-c), as well as lipid ratios (TC/HDL-c and TGs/HDL-c). In contrast, pretreatment with A. ageratum L EO for seven days demonstrated a notable preventive effect against the rise plasma lipid levels and lipid ratios. In summary, this study reveals the promising potential of A. ageratum L EO in managing hyperlipidemia, which highlights the necessity for further research to elucidate the specific mechanistic pathways implicated.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
